Aromatase - A brief overview

被引:567
作者
Simpson, ER [1 ]
Clyne, C
Rubin, G
Boon, WC
Robertson, K
Britt, K
Speed, C
Jones, M
机构
[1] Monash Univ, Prince Henrys Inst Med Res, Melbourne, Vic 3004, Australia
[2] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia
关键词
estrogen biosynthesis; gene; tissue-specific expression; extragonadal synthesis; cancer; new therapeutic concepts;
D O I
10.1146/annurev.physiol.64.081601.142703
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
There is growing awareness that androgens and estrogens have general metabolic roles that are not directly involved in reproductive processes. These include actions on vascular function, lipid and carbohydrate metabolism, as well as bone mineralization and epiphyseal closure in both sexes. In postmenopausal women, as in men, estrogen is no longer solely an endocrine factor but instead is produced in a number of extragonadal sites and acts locally at these sites in a paracrine and intracrine fashion. These sites include breast, bone, vasculature, and brain. Within these sites, aromatase action can generate high levels of estradiol locally without significantly affecting circulating levels. Circulating C-19 steroid precursors are essential substrates for extragonadal estrogen synthesis. The levels of these androgenic precursors decline markedly with advancing age in women, possible from the mid-to-late reproductive years. This may be a fundamental reason why women are at increased risk for bone mineral loss and fracture, and possibly decline of cognitive function, compared with men. Aromatase expression in these various sites is under the control of tissue-specific promotors regulated by different cohorts of transcription factors. Thus in principle, it should be possible to develop selective aromatase modulators (SAMs) that block aromatase expression, for example, in breast, but allow unimpaired estrogen synthesis in other tissues such as bone.
引用
收藏
页码:93 / 127
页数:35
相关论文
共 143 条
[11]   ANDROSTENEDIONE METABOLISM IN CULTURED HUMAN OSTEOBLAST-LIKE CELLS [J].
BRUCH, HR ;
WOLF, L ;
BUDDE, R ;
ROMALO, G ;
SCHWEIKERT, HU .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 75 (01) :101-105
[12]   Genomic organization of the bovine aromatase encoding gene and a homologous pseudogene as revealed by DNA fiber FISH [J].
Brunner, RM ;
Goldammer, T ;
Fürbass, R ;
Vanselow, J ;
Schwerin, M .
CYTOGENETICS AND CELL GENETICS, 1998, 82 (1-2) :37-40
[13]  
Bulun S E, 1994, J Clin Endocrinol Metab, V78, P1616, DOI 10.1210/jc.78.2.1616
[14]   CYP19 (AROMATASE CYTOCHROME-P450) GENE-EXPRESSION IN HUMAN-MALIGNANT ENDOMETRIAL TUMORS [J].
BULUN, SE ;
ECONOMOS, K ;
MILLER, D ;
SIMPSON, ER .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (06) :1831-1834
[15]   Distribution of aromatase P450 transcripts and adipose fibroblasts in the human breast [J].
Bulun, SE ;
Sharda, G ;
Rink, J ;
Sharma, S ;
Simpson, ER .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (03) :1273-1277
[16]   COMPETITIVE REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION ANALYSIS INDICATES THAT LEVELS OF AROMATASE CYTOCHROME-P450 TRANSCRIPTS IN ADIPOSE-TISSUE OF BUTTOCKS, THIGHS, AND ABDOMEN OF WOMEN INCREASE WITH ADVANCING AGE [J].
BULUN, SE ;
SIMPSON, ER .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (02) :428-432
[17]   PHYLOGENETIC DISTRIBUTION OF AROMATASE AND OTHER ANDROGEN-CONVERTING ENZYMES IN CENTRAL NERVOUS-SYSTEM [J].
CALLARD, GV ;
PETRO, Z ;
RYAN, KJ .
ENDOCRINOLOGY, 1978, 103 (06) :2283-2290
[18]   AROMATIZATION AND 5-ALPHA-REDUCTION IN BRAIN AND NON-NEURAL TISSUES OF A CYCLOSTOME, PETROMYZON-MARINUS [J].
CALLARD, GV ;
PETRO, Z ;
RYAN, KJ .
GENERAL AND COMPARATIVE ENDOCRINOLOGY, 1980, 42 (02) :155-159
[19]  
CALLARD GV, 1981, BRAIN RES, V204, P451
[20]   Effect of testosterone and estradiol in a man with aromatase deficiency [J].
Carani, C ;
Qin, K ;
Simoni, M ;
FaustiniFustini, M ;
Serpente, S ;
Boyd, J ;
Korach, KS ;
Simpson, ER .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (02) :91-95